VVP
GILD icon

Venture Visionary Partners’s Gilead Sciences GILD Stock Holding History

Venture Visionary Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$774K Sell
6,128
-144
-2% -$19K 0.02% 390
2026
Q1 		$874K Sell
6,272
-150
-2% -$21K 0.03% 337
2025
Q4 		$788K Buy
6,422
+76
+1% +$9.24K 0.03% 350
2025
Q3 		$704K Buy
6,346
+189
+3% +$21.5K 0.02% 350
2025
Q2 		$683K Sell
6,157
-224
-4% -$23.8K 0.03% 343
2025
Q1 		$715K Sell
6,381
-505
-7% -$52.1K 0.03% 324
2024
Q4 		$636K Sell
6,886
-819
-11% -$73.7K 0.03% 322
2024
Q3 		$646K Sell
7,705
-683
-8% -$52.1K 0.03% 329
2024
Q2 		$576K Buy
8,388
+967
+13% +$64.5K 0.03% 351
2024
Q1 		$544K Buy
7,421
+69
+0.9% +$5.31K 0.03% 361
2023
Q4 		$596K Buy
7,352
+333
+5% +$25.9K 0.03% 332
2023
Q3 		$526K Sell
7,019
-476
-6% -$36.6K 0.03% 321
2023
Q2 		$578K Sell
7,495
-295
-4% -$23.5K 0.03% 317
2023
Q1 		$646K Sell
7,790
-380
-5% -$31.5K 0.04% 296
2022
Q4 		$701K Sell
8,170
-411
-5% -$32.5K 0.05% 267
2022
Q3 		$529K Sell
8,581
-26,032
-75% -$1.64M 0.04% 293
2022
Q2 		$2.14M Sell
34,613
-8,787
-20% -$544K 0.16% 118
2022
Q1 		$2.58M Sell
43,400
-5,974
-12% -$382K 0.17% 115
2021
Q4 		$3.62M Buy
49,374
+2,903
+6% +$200K 0.24% 95
2021
Q3 		$3.27M Buy
46,471
+6,827
+17% +$480K 0.23% 95
2021
Q2 		$2.79M Buy
39,644
+21,362
+117% +$1.43M 0.22% 100
2021
Q1 		$1.18M Buy
18,282
+11,311
+162% +$729K 0.1% 179
2020
Q4 		$406K Buy
+6,971
New +$421K 0.04% 268

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Venture Visionary Partners's GILD Position: Q2 2026 in Review

Venture Visionary Partners reduced its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, selling an estimated $19K and leaving 6,128 shares worth $774K. The position accounts for 0.02% of the portfolio, ranked #390.

Venture Visionary Partners first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.62M in Q4 2021. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Venture Visionary Partners held 6,128 shares of Gilead Sciences worth $774K as of Q2 2026.
  • Venture Visionary Partners sold 144 Gilead Sciences shares in Q2 2026, an estimated $19K.
  • Gilead Sciences made up 0.02% of Venture Visionary Partners's portfolio in Q2 2026, its #390 holding.
  • Venture Visionary Partners first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Venture Visionary Partners's Gilead Sciences position peaked at $3.62M in Q4 2021.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.